Ozempic and Eating Disorders: Why GLP-1 Medications Can Be Risky

The Rise of GLP-1 Medications
GLP-1 receptor agonists like Ozempic (semaglutide), Wegovy, and Mounjaro (tirzepatide) are becoming increasingly popular for type 2 diabetes management and weight loss. These medications work by slowing digestion, reducing appetite, and regulating blood sugar.
But while GLP-1s can be life-changing for some, they carry serious risks for individuals with a history of eating disorders.

GLP-1 Medications and Eating Disorders: A Dangerous Combination
For people with anorexia, bulimia, ARFID, or binge eating disorder, medications that alter appetite and weight can worsen symptoms or trigger relapse.

Contraindications to Consider:

• Appetite Suppression - For someone recovering from anorexia or restrictive eating, the medication can reinforce harmful food avoidance.
• Rapid Weight Loss -GLP-1s can lead to fast, dramatic weight changes — which may trigger obsessive behaviors or compulsive exercise.
• Gastrointestinal Side Effects - Nausea, vomiting, diarrhea, and abdominal pain are common. For those with purging behaviors, this overlap can mask warning signs or worsen health risks.
• Psychological Impact - Weight loss focus can reinforce distorted body image or perfectionism. Even in binge eating disorder, appetite reduction may not address the emotional roots of the condition.
• Nutritional Deficiencies - When appetite is suppressed, people may not meet basic nutritional needs, compounding the risks already present in eating disorders.

What the Experts Say
Professional organizations like the National Eating Disorders Association (NEDA) and eating disorder treatment programs caution against prescribing GLP-1s to individuals with active or past eating disorders.
The concern isn’t just about relapse — it’s that GLP-1 medications can mimic or amplify the symptoms of the disorder itself, making recovery much harder.


Safer Alternatives for Eating Disorder Treatment
Instead of focusing on medications that suppress appetite or reduce weight, treatment approaches for eating disorders emphasize:

• Evidence-based therapies like CBT-E, DBT, ACT, and family-based treatment.
• Nutritional rehabilitation guided by registered dietitians specializing in eating disorders.
• Holistic support including medical monitoring, therapy, and, when appropriate, medication that targets anxiety, depression, or OCD tendencies.

Key Takeaway
While Ozempic and other GLP-1s are being widely promoted, they are not safe or appropriate for individuals with eating disorders. The risk of relapse, medical complications, and worsening symptoms outweighs any potential benefit.
​
If you or someone you love has an eating disorder and is considering GLP-1 medication, it’s essential to speak with a healthcare provider experienced in both eating disorders and metabolic health.